Memphasys旗下Felix系统获CE标志认证,全面开启欧洲及其他地区商业部署

美股速递
Dec 29, 2025

生物技术公司Memphasys宣布,其创新的Felix系统已成功获得CE标志认证。这一关键性监管批准为该公司在欧洲及其他认可CE标志的市场进行全面商业部署扫清了道路。CE标志认证表明该产品符合欧盟健康、安全和环保标准,是进入欧洲经济区自由流通的必要条件。此次获批标志着Memphasys在全球商业化进程中迈出了重要一步,有望显著提升其产品在全球范围内的市场渗透能力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10